Customer Center
Login | Register

Investor Relations

  • Banner Image

News Releases

Date Title  
Toggle Summary Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results
AUSTIN, Texas , Feb. 4, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full-year 2018.  Financial and operating highlights for the quarter and full-year include: On December 31, 2018 , the Company closed the acquisition of EMD
Toggle Summary Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2018; Company to Present at 37th Annual J.P. Morgan Healthcare Conference
AUSTIN, Texas , Jan. 7, 2019 /PRNewswire/ --  Luminex Corporation (Nasdaq: LMNX) today announced that it expects its revenues in the fourth quarter of 2018 to be approximately $81 million and to exceed $315 million for the full- year ended 2018, near the top of the previously communicated guidance
Toggle Summary Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio
AUSTIN, Texas , Jan. 2, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ: LMNX) today announced that the company has completed its previously announced acquisition of MilliporeSigma's flow cytometry portfolio for $75 million in combined stock, asset and inventory purchases.